Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Condamine

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cell Reports|December 30, 2020
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in CancerTaekyoung Kwak, Fang Wang, Hui Deng, et al.
The Journal of Experimental Medicine|June 27, 2019
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCsJérôme Mastio, Thomas Condamine, George Dominguez, et al.
Nature Ecology & Evolution|March 13, 2019
The genome of the jellyfish Clytia hemisphaerica and the evolution of the cnidarian life-cycleLucas Leclère, Coralie Horin, Sandra Chevalier, et al.
Nature Medicine|February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Nature Communications|January 15, 2025
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical modelsStefano Pierini, Rashid Gabbasov, Maria Cecilia Oliveira-Nunes, et al.
Cancer Cell|November 15, 2017
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of TumorsVinit Kumar, Laxminarasimha Donthireddy, Douglas Marvel, et al.
Science Immunology|April 19, 2017
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patientsThomas Condamine, George A Dominguez, Je-In Youn, et al.
Nature Communications|July 22, 2021
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockadeCecile Geuijen, Paul Tacken, Liang-Chuan Wang, et al.
EMBO Molecular Medicine|December 29, 2020
Immunodynamics of explanted human tumors for immuno-oncologyAgathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cell Reports|December 30, 2020
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in CancerTaekyoung Kwak, Fang Wang, Hui Deng, et al.
The Journal of Experimental Medicine|June 27, 2019
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCsJérôme Mastio, Thomas Condamine, George Dominguez, et al.
Nature Ecology & Evolution|March 13, 2019
The genome of the jellyfish Clytia hemisphaerica and the evolution of the cnidarian life-cycleLucas Leclère, Coralie Horin, Sandra Chevalier, et al.
Nature Medicine|February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Nature Communications|January 15, 2025
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical modelsStefano Pierini, Rashid Gabbasov, Maria Cecilia Oliveira-Nunes, et al.
Cancer Cell|November 15, 2017
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of TumorsVinit Kumar, Laxminarasimha Donthireddy, Douglas Marvel, et al.
Science Immunology|April 19, 2017
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patientsThomas Condamine, George A Dominguez, Je-In Youn, et al.
Nature Communications|July 22, 2021
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockadeCecile Geuijen, Paul Tacken, Liang-Chuan Wang, et al.
EMBO Molecular Medicine|December 29, 2020
Immunodynamics of explanted human tumors for immuno-oncologyAgathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, et al.
Pageof 3